A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model-Reference-Cited by-同舟云学术

A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model

Published:2015-01 Issue:2 Volume:356 Page:676-685
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ahn Euri,Kim Ha,Han Kyusun Torque,Sin Jeong-Im

Funder

National Research Foundation of Korea (NRF)

Kangwon National University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. The carcinoembryonic antigen gene family: structure, expression and evolution;Thompson;Tumor Biol,1988

2. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives;Thompson;J. Clin. Lab. Anal,1991

3. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine;Kantor;J. Natl. Cancer Inst,1992

4. Carcinoembryonic antigen as a target for cancer vaccines;Hodge;Cancer Immunol. Immunother,1996

5. Selected strategies to augment polynucleotide immunization;Conry;Gene Ther,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis;iScience;2022-12

2. Nonenveloped Virus-Like Particles: A Promising Antigen-Delivery Strategy for the Induction of Antitumor Immune Responses;Nano LIFE;2022-11-14

3. CAD v1.0: Cancer Antigens Database Platform for Cancer Antigen Algorithm Development and Information Exploration;Frontiers in Bioengineering and Biotechnology;2022-05-12

4. Across-Cancer Immune Responses Induced by Nanovaccines or Microvaccines to Prevent Different Cancers and Cancer Metastasis;SSRN Electronic Journal;2022

5. B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B;Cellular Immunology;2021-09